Marinus Presents Additional Data from Ganaxolone Phase 2 Trial in Refractory Status Epilepticus at the American Epilepsy Society Annual Meeting

Ads

You May Also Like

Midatech commences US clinical study of its investigational treatment for fatal childhood brain cancer

25 May 2018 Midatech Pharma PLC(“Midatech”, “Company” or “Group”) Midatech commences US clinical study ...

Genedrive PLC: Commercial sales of Genedrive® HCV ID Kit and platform begin

13 March 2018 genedrive plc ("genedrive" or the "Company") Commercial sales of Genedrive® HCV ...

TSI Healthcare Named Top EHR for Rheumatology in Black Book Survey

CHAPEL HILL, N.C., March 08, 2016 (GLOBE NEWSWIRE) -- TSI Healthcare, a national leader ...